Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Metabolic Myopathies

Tarnopolsky, Mark A. · 2016 · Continuum

Abstract

PURPOSE OF REVIEW: Metabolic myopathies are genetic disorders that impair intermediary metabolism in skeletal muscle. Impairments in glycolysis/glycogenolysis (glycogen-storage disease), fatty acid transport and oxidation (fatty acid oxidation defects), and the mitochondrial respiratory chain (mitochondrial myopathies) represent the majority of known defects. The purpose of this review is to develop a diagnostic and treatment algorithm for the metabolic myopathies. RECENT FINDINGS: The metabolic myopathies can present in the neonatal and infant period as part of more systemic involvement with hypotonia, hypoglycemia, and encephalopathy; however, most cases present in childhood or in adulthood with exercise intolerance (often with rhabdomyolysis) and weakness. The glycogen-storage diseases present during brief bouts of high-intensity exercise, whereas fatty acid oxidation defects and mitochondrial myopathies present during a long-duration/low-intensity endurance-type activity or during fasting or another metabolically stressful event (eg, surgery, fever). The clinical examination is often normal between acute events, and evaluation involves exercise testing, blood testing (creatine kinase, acylcarnitine profile, lactate, amino acids), urine organic acids (ketones, dicarboxylic acids, 3-methylglutaconic acid), muscle biopsy (histology, ultrastructure, enzyme testing), MRI/spectroscopy, and targeted or untargeted genetic testing. SUMMARY: Accurate and early identification of metabolic myopathies can lead to therapeutic interventions with lifestyle and nutritional modification, cofactor treatment, and rapid treatment of rhabdomyolysis.

Overview

Integrity signals

Registry

Crossref · 10.1212/con.0000000000000403

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 91 references

Research works printed but not linked: 1

  1. Tarnopolsky MA Roy BD MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997;20(12):1502–1509. doi:10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C. · DOI · Paper page

Cited by

See all 61

Metadata

Authors
Tarnopolsky, M. A.
Corresponding author
Tarnopolsky, Mark A.
Venue
Continuum
Published
2016-12
Volume
22
Issue
6
Pages
1829-1851
ISSN
  • 1080-2371 (ISSN-L)
  • 1538-6899
OpenAlex
W4245914306
Cited by
61
References
91
Citations by year
2026: 2 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 12 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 2 · 2017: 2 · 2016: 1
FWCI
3.95
Type
journal article
Language
en
Open access
closed
Locations
  • CONTINUUM Lifelong Learning in Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
metabolic myopathies, skeletal muscle metabolism, glycogen storage disease, fatty acid oxidation disorders, mitochondrial myopathy, exercise intolerance, rhabdomyolysis, diagnostic algorithm, acylcarnitine profile, urinary organic acids, muscle biopsy, creatine kinase, hypoglycemia, hypotonia, genetic testing
MeSH terms
Female, Glycogen Storage Disease Type V, Glycogen Storage Disease Type VII, Humans, Male, Metabolism, Inborn Errors, Middle Aged, Muscular Diseases, Rhabdomyolysis, Mitochondrial Myopathies, Glycogenolysis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Myopathies. https://app.cochat.ai/papers/10.1212/con.0000000000000403
The paper
Tarnopolsky, M. A. (2016). Metabolic Myopathies. Continuum. https://doi.org/10.1212/con.0000000000000403

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.